MedicineThe innovative development of medical devices is directly related to the level of public health protection. In 2022, the market size of China's medical device industry is expected to reach 958.2 billion yuan.RMB 100 million, with a compound annual growth rate (CAGR) of approximately 17.5% over the past seven years, it has surged to become the world’s second-largest market after the United States. The Chinese medical device industry is expected to maintain its rapid growth momentum, with the market size projected to reach RMB 1,244.7 billion by 2025.

The market size is substantial, yet there remains a significant gap between China and developed countries in terms of industrial development level and innovation capacity. In certain fields, medical devices are still dominated by imported products, and breakthroughs in key “chokepoint” technologies require continuous efforts. As a strategic emerging industry characterized by multidisciplinary integration, knowledge intensity, and high value-added, the medical device sector relies on technological innovation as the key driver for sustainable development. Collaboration among industry, academia, research institutions, and healthcare providers is a strategic measure to accelerate industry innovation, facilitate the translation of scientific and technological achievements, and enhance the competitiveness of products and enterprises. It is also an inevitable path for the high-end development of China’s medical device industry.

Therefore, the rapid development of the medical device sector hinges on the construction of an innovation ecosystem. This entails active participation from multiple stakeholders—including universities, enterprises, R&D institutions, and healthcare providers—to foster interdisciplinary integration between medicine and engineering. Such collaboration promotes the deep convergence of production, education, research, and clinical application in the medical device industry, thereby providing essential technological reserves and innovative vitality for industrial growth.

Currently, through the joint efforts of diverse market participants, China’s medical device industry has initiated a sustainable model for collaborative innovation across industry, academia, and research. While local governments emphasize the industrial leadership and scale effects of large enterprises, they should also support innovative small and medium-sized enterprises (SMEs), actively promote integrated cooperation among large, medium, and small businesses, leverage capital resources along with the manufacturing and channel advantages of large corporations, and supplement these efforts with national preferential policies for the registration and procurement of innovative products. These measures will accelerate the industrialization of innovative products from all parties, thereby truly steering China’s medical device industry toward an autonomous, high-end, and innovation-driven future.

To promote the collaborative innovation and development among China’s medical device industry, academia, research institutions, and healthcare providers, the 7th Future Healthcare 100 Conference was jointly organized with Proxima Ventures.Forum on the Clinical Application of Interdisciplinary Technologies in Medical Devices, focusing on hot topics such as industry trends, innovative applications, and interdisciplinary collaboration, to provide effective support for technological innovation in the medical device sector, thereby facilitating resource and technology sharing, promoting new breakthroughs in medical device technologies, and creating new value.

(I)Industry Trends: A New Milestone in the Innovative Development of Medical Devices

Amid the impact of the COVID-19 pandemic, the global medical device industry has accelerated its iteration and updates, driving innovations in both market scale and product functionality that continuously advance healthcare. China has also placed high priority on fostering innovation within its medical device sector, with regulatory authorities introducing multiple policies to encourage faster innovation among domestically produced medical devices. As a result, China’s medical device industry has demonstrated strong resilience and competitive advantages in innovative development. To this end, the forum has specially invited clinical experts and representatives from global growth consulting firms to share cutting-edge insights.

(II)Practical Dialogue: Integrating Medical Innovation, Intelligently Crafting a Healthy Future

As internal factors such as technological advancements and the maturation of the industrial chain lay a solid foundation for the development of domestically produced medical devices, and external factors including supportive policies and capital investment create historic opportunities, a wave of innovation has swept through the medical device sector. Consequently, medical devices have become one of the most prominent segments within China’s broader health industry. Driven by these multiple catalysts, local enterprises are gradually rising, with outstanding companies emerging in rapid succession. The forum also invites innovative companies from diverse scenarios to engage in interactive dialogues, facilitating in-depth sharing of technological and practical innovations.

Forum Schedule: May 5–7, 2023

Forum Venue: Shanghai · Zhangjiang Science Hall

Forum Name: Forum on the Clinical Application of Interdisciplinary Technologies in Medical Devices

Forum Organizer: VB100, VCBeat, VCBeat

Forum Supporting Organizations: Proxima Ventures

Attending Companies: Antai Micro Precision, Chaoguangwei Medical, Greater Bay Biotech, Darui Technology, Dunbo Medical, Feidun Medical, Frost & Sullivan, Hanzandi, Hengle Medical, Jianshi Technology, Kangfeng Biotech, LinkMed Valley, NanoVision, Puluo Medical, Ruining Biotech, Ruidi Biotech, Shitong Medical, Weiqiang Medical, Yichao Technology

※Listed alphabetically by company name; no ranking is implied. More companies are being confirmed.

Forum Agenda Planning:

Clinical Application of Innovative Medical Devices

Global Trends in the Medical Device Industry

Pioneering Innovative Technologies to Build a Diagnostic and Therapeutic Platform for Major Diseases

Promoting Interdisciplinary Integration to Facilitate the Clinical Application of Technological Innovations

Accelerating Intelligent Automation to Embrace a New Future for Life and Health

※ Preliminary agenda items are for reference only; final agenda items are subject to on-site confirmation.

# View Full Conference Agenda >>

# Join the Conference Group Chat >>